Prelude Capital Management, LLC Simulations Plus, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$14.65 - $23.75 $19,176 - $31,088	-1,309 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$14.4 - $16.8 $18,720 - $21,840	-1,300 Reduced 49.83%	1,309 $19,000
Q4 2017 Feb 14, 2018	SELL	$15.3 - $17.4 $12,102 - $13,763	-791 Reduced 23.26%	2,609 $42,000
Q3 2017 Nov 14, 2017	BUY	$13.7 - $15.65 $46,580 - $53,210	3,400	3,400 $53,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $648M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.